<?xml version="1.0" encoding="UTF-8"?>
<ref id="B106-vaccines-07-00053">
 <label>106.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Safronetz</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Falzarano</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Scott</surname>
    <given-names>D.P.</given-names>
   </name>
   <name>
    <surname>Furuta</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Feldmann</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Gowen</surname>
    <given-names>B.B.</given-names>
   </name>
  </person-group>
  <article-title>Antiviral efficacy of favipiravir against two prominent etiological agents of hantavirus pulmonary syndrome</article-title>
  <source>Antimicrob. Agents Chemother.</source>
  <year>2013</year>
  <volume>57</volume>
  <fpage>4673</fpage>
  <lpage>4680</lpage>
  <pub-id pub-id-type="doi">10.1128/AAC.00886-13</pub-id>
  <?supplied-pmid 23856782?>
  <pub-id pub-id-type="pmid">23856782</pub-id>
 </element-citation>
</ref>
